{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:21:59Z","timestamp":1793701319229,"version":"4.5.1"},"reference-count":27,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1253\/circj.cj-11-0699","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T10:50:30Z","timestamp":1322823030000},"page":"71-78","source":"Crossref","is-referenced-by-count":29,"title":["Clinical Outcomes Following Coronary Stenting in Japanese Patients Treated With and Without Proton Pump Inhibitor"],"prefix":"10.1253","volume":"76","author":[{"given":"Tadasuke","family":"Chitose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hokimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Miyao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoki","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Mizobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"on behalf of Kumamoto Intervention","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.261"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. Can Med Assoc J 2009; 180: 713-718.","DOI":"10.1503\/cmaj.082001"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.01.348"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Stockl KM, Le L, Zakharyan A, Harada AS, Solow BK, Addiego JE, et al. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med 2010; 170: 704-710.","DOI":"10.1001\/archinternmed.2010.34"},{"issue":"6","key":"5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-152-6-201003160-00003","volume":"152","author":"RAY WAYNE A.","year":"2010","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"6","unstructured":"6. Food and Drug Administration. Drug safety communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm203888.htm (accessed April 28, 2010)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, et al. Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 2000; 84: 891-896.","DOI":"10.1055\/s-0037-1614133"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.8.821"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61525-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010; 363: 1909-1917.","DOI":"10.1056\/NEJMoa1007964"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2010.10.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Xie HG, Stein CM, Kim RB, Wilkinson GR, Flockhart DA, Wood AJ. Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. Pharmacogenetics 1999; 9: 539-549.","DOI":"10.1097\/00008571-199910000-00001"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.20.300"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199702000-00008"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.187397"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2009.04.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, et al. ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 2010; 122: 2619-2633.","DOI":"10.1161\/CIR.0b013e318202f701"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0913"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hokimoto S, Yamamoto K, Ogawa H, Kaikita K, Ono T, Nakagawa K. Is impact of proton pump inhibitor on platelet reactivity to clopidogrel a class effect? Circulation 2009; 120: S1033.","DOI":"10.1161\/circ.120.suppl_18.S1033"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hulot JS, Collet JP, Silvain J, Pena A, Bellemain-Appaix A, Barthelemy O, et al. Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: A systematic meta-analysis. J Am Coll Cardiol 2010; 56: 134-143.","DOI":"10.1016\/j.jacc.2009.12.071"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J 2009; 157: 148 e141-e145.","DOI":"10.1016\/j.ahj.2008.09.017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cuisset T, Frere C, Quilici J, Poyet R, Gaborit B, Bali L, et al. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. J Am Coll Cardiol 2009; 54: 1149-1153.","DOI":"10.1016\/j.jacc.2009.05.050"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597-607.","DOI":"10.1253\/circj.CJ-09-0982"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hoshino K, Horiuchi H, Tada T, Tazaki J, Nishi E, Kawato M, et al. Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention. Circ J 2009; 73: 336-342.","DOI":"10.1253\/circj.CJ-08-0559"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2011.03.002"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2011.01.003"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009343005"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:18:51Z","timestamp":1741976331000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/76\/1\/76_CJ-11-0699\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-11-0699","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}